Aim. Basal cell carcinoma (BCC) is the most frequent neoplasm in Caucasian population; patients with a history of BCC are considered to be at risk of developing a subsequent BCC or another cancer of the skin. The purpose of this study was to evaluate the risk in a group of Italian patients with a history of a first BCC. Methods. The group was composed of 322 patients (143 female, 179 male), with a mean age of 68.43 years, already treated for BCC In the period 1994-96. The median follow-up period was 6.1 years. Results. A second BCC occurred during the study period in 37.5% of the subjects. Men were at higher risk than women. The risk increased after the age of 40 with a peak after 60 years. The second BCC was localised in the same site as the first BCC. A total of 36 (11.2%) subjects had another precancerous disease or skin cancer (Actinic keratosis, Bowen's disease or squamous cell carcinoma, melanoma); 85% of the patients with multiple BCC developed a second BCC. Patients with a hist...
Risk of developing a new basal cell carcinoma or other skin neoplasms in patients already treated for a basal cell carcinoma
VIRGILI, Anna
2004
Abstract
Aim. Basal cell carcinoma (BCC) is the most frequent neoplasm in Caucasian population; patients with a history of BCC are considered to be at risk of developing a subsequent BCC or another cancer of the skin. The purpose of this study was to evaluate the risk in a group of Italian patients with a history of a first BCC. Methods. The group was composed of 322 patients (143 female, 179 male), with a mean age of 68.43 years, already treated for BCC In the period 1994-96. The median follow-up period was 6.1 years. Results. A second BCC occurred during the study period in 37.5% of the subjects. Men were at higher risk than women. The risk increased after the age of 40 with a peak after 60 years. The second BCC was localised in the same site as the first BCC. A total of 36 (11.2%) subjects had another precancerous disease or skin cancer (Actinic keratosis, Bowen's disease or squamous cell carcinoma, melanoma); 85% of the patients with multiple BCC developed a second BCC. Patients with a hist...I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
